SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001140361-14-020178
Filing Date
2014-05-12
Accepted
2014-05-12 16:25:06
Documents
11
Period of Report
2013-03-31

Document Format Files

Seq Description Document Type Size
1 RAPTOR PHARMACEUTICALS CORP 10-Q A 3-31-2013 form10qa.htm 10-Q/A 1062898
2 EXHIBIT 15.1 ex15_1.htm EX-15.1 3937
3 EXHIBIT 31.1 ex31_1.htm EX-31.1 8289
4 EXHIBIT 31.2 ex31_2.htm EX-31.2 8485
5 EXHIBIT 32.1 ex32_1.htm EX-32.1 7226
  Complete submission text file 0001140361-14-020178.txt   6969094

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT rptp-20130331.xml EX-101.INS 1010009
7 XBRL TAXONOMY EXTENSION SCHEMA rptp-20130331.xsd EX-101.SCH 48273
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE rptp-20130331_cal.xml EX-101.CAL 50853
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE rptp-20130331_def.xml EX-101.DEF 182392
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE rptp-20130331_lab.xml EX-101.LAB 660829
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rptp-20130331_pre.xml EX-101.PRE 335852
Mailing Address 5 HAMILTON LANDING SUITE 160 NOVATO CA 94949
Business Address 5 HAMILTON LANDING SUITE 160 NOVATO CA 94949 415-408-6200
Raptor Pharmaceutical Corp (Filer) CIK: 0001070698 (see all company filings)

IRS No.: 860883978 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q/A | Act: 34 | File No.: 000-25571 | Film No.: 14833705
SIC: 2834 Pharmaceutical Preparations